Bourne M, Szabadi E, Bradshaw C M
Department of Psychiatry, University of Manchester, UK.
Eur J Clin Pharmacol. 1993;44(1):57-62. doi: 10.1007/BF00315281.
We have studied the effects of single oral doses of amoxapine (100 mg and 200 mg), amitriptyline (50 mg and 100 mg), and placebo on some autonomic functions in ten healthy volunteers, using a balanced double-blind crossover design. Amitriptyline significantly reduced salivation and it significantly attenuated both miosis evoked by locally applied pilocarpine and sweat secretion evoked by locally applied carbachol. Amoxapine did not significantly alter any of these measures. Neither treatment significantly altered the pupillary light reflex (latency, amplitude, or 75% recovery time). Resting pupil diameter was significantly reduced by the higher dose of amoxapine but was not affected by the other treatments. The higher dose of amoxapine significantly increased supine systolic blood pressure, but did not affect heart rate or diastolic blood pressure; amitriptyline had no effect on any of these cardiovascular measures. These results confirm the antimuscarinic effects of amitriptyline in man, but provide no evidence for antimuscarinic effects of amoxapine.
我们采用平衡双盲交叉设计,研究了单次口服剂量的阿莫沙平(100毫克和200毫克)、阿米替林(50毫克和100毫克)及安慰剂对10名健康志愿者某些自主神经功能的影响。阿米替林显著减少唾液分泌,并且显著减弱局部应用毛果芸香碱诱发的瞳孔缩小以及局部应用卡巴胆碱诱发的汗液分泌。阿莫沙平未显著改变上述任何指标。两种治疗均未显著改变瞳孔对光反射(潜伏期、幅度或75%恢复时间)。较高剂量的阿莫沙平使静息瞳孔直径显著减小,但其他治疗对此无影响。较高剂量的阿莫沙平显著升高仰卧位收缩压,但不影响心率或舒张压;阿米替林对这些心血管指标均无影响。这些结果证实了阿米替林在人体中的抗毒蕈碱作用,但未提供阿莫沙平具有抗毒蕈碱作用的证据。